Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)
China · Delayed Price · Currency is CNY 5.49
-0.12 (-2.14%)
Aug 24, 2026, 4:00 PM EDT
SHE:300511 Revenue
Shanghai Xuerong Biotechnology had revenue of 477.38M CNY in the quarter ending June 30, 2026, with 36.40% growth. This brings the company's revenue in the last twelve months to 2.35B, up 25.02% year-over-year. In the year 2025, Shanghai Xuerong Biotechnology had annual revenue of 1.99B, down -8.09%.
Revenue (ttm)
2.35B
Revenue Growth
+25.02%
P/S Ratio
1.50
Revenue / Employee
1.23M
Employees
1,920
Market Cap
3.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.99B | -174.83M | -8.09% |
| Dec 31, 2024 | 2.16B | -402.69M | -15.70% |
| Dec 31, 2023 | 2.57B | 244.71M | 10.55% |
| Jan 1, 2023 | 2.32B | 247.30M | 11.93% |
| Jan 1, 2022 | 2.07B | -129.06M | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.